Breast Cancer Research and Treatment · 2009 · 43 citations · 41 references
Life SciencesMolecular BiologyOncologyCell CycleCell SignalingSignal TransductionCell Cycle ControlCell Cycle SignalingCell Cycle TransitionsCell-cycle ProgressionCell-cycle RegulationSignal Transduction In CancerBreast Cancer ProgressionCell Cycle Control ProteinsCell Cycle Regulatory NetworksEgfr DependenceEgfr InhibitionErbb Receptor SignalingErlotinib TherapyHer2 Receptor Signaling
41
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Anne Brunet, Azad Bonni, Michael J. Zigmond et al. · Cell · 1999 · 6.6K citations · Full text
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Andrea C. Carrano, Esther Eytan, Avram Hershko et al. · Nature Cell Biology · 1999 · 1.5K citations
Shirin Khambata‐Ford, Christopher R. Garrett, Neal J. Meropol et al. · Journal of Clinical Oncology · 2007 · 1.1K citations · Full text
Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3
Natalia Sergina, Megan Rausch, Donghui Wang et al. · Nature · 2007 · 989 citations · Full text
Medicine, Cancer Biology, Oncology +14
Cyclin E-CDK2 is a regulator of p27Kip1.
Robert J. Sheaff, Mark Groudine, Michael D. Gordon et al. · Genes & Development · 1997 · 927 citations · Full text